Peter Clayton

19.0k total citations · 2 hit papers
305 papers, 9.5k citations indexed

About

Peter Clayton is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Peter Clayton has authored 305 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Endocrinology, Diabetes and Metabolism, 75 papers in Molecular Biology and 69 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Peter Clayton's work include Growth Hormone and Insulin-like Growth Factors (126 papers), Birth, Development, and Health (39 papers) and Sexual Differentiation and Disorders (29 papers). Peter Clayton is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (126 papers), Birth, Development, and Health (39 papers) and Sexual Differentiation and Disorders (29 papers). Peter Clayton collaborates with scholars based in United Kingdom, United States and Australia. Peter Clayton's co-authors include Philip Murray, Matthew S. Gill, Stephen M. Shalet, Andrew Whatmore, Leena Patel, Indraneel Banerjee, Alan D. Rogol, David A. Price, David A. Price and S M Shalet and has published in prestigious journals such as Science, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Peter Clayton

298 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extension of Life-Span with Superoxide Dismutase/Catalase Mimetics

2000 719 citations Matthew S. Gill, Peter Clayton et al. profile →
Management of the Child Born Small for Gestational Age through to Adulthood: A Consensus Statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society

2007 515 citations Peter Clayton et al. The Journal of Clinical Endocrinology & Metabolism profile →

Peers

Countries citing papers authored by Peter Clayton

Since Specialization

Citations

This map shows the geographic impact of Peter Clayton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Clayton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Clayton more than expected).

Fields of papers citing papers by Peter Clayton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Clayton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Clayton. The network helps show where Peter Clayton may publish in the future.

Co-authorship network of co-authors of Peter Clayton

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Clayton. A scholar is included among the top collaborators of Peter Clayton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Clayton. Peter Clayton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Performance of renin assays in selecting fludrocortisone dose in children with adrenal disorders 2024 ·Endocrine Connections ·Timothy J. Morris, Andrew Whatmore, (unknown), (unknown), Eric S Kilpatrick, Lesley Tetlow, Peter Clayton	1
2	Diagnosis of childhood and adolescent growth hormone deficiency using transcriptomic data 2023 ·Frontiers in Endocrinology ·(unknown), (unknown), Andrew Whatmore, Peter Clayton, Adam Stevens, Philip Murray	1
3	Growth of twins conceived using assisted reproductive treatments up to 5 years old: a national growth cohort 2023 ·Human Reproduction ·(unknown), Peter Clayton, Matthew Gittins, Stephen W. D’Souza, Daniel R. Brison, Stephen A. Roberts	0
4	A 7-Year Update Report of a National, Interdisciplinary Endeavour to Improve Outcomes for Children and Young People Under 19 Years of Age with Hypothalamic Pituitary Axis Tumours (HPAT) Using Multi-site Video Conferencing 2018 ·(unknown), (unknown), Antonia Dastamani, Neil Dorward, Kristian Aquilina, (unknown), Kshitij Mankad, Benedetta Pettorini, (unknown), (unknown), Peter Clayton, Darren Hargrave, Márta Korbonits, Helen Spoudeas	2
5	Transcriptomics and machine learning predict diagnosis and severity of growth hormone deficiency 2018 ·JCI Insight ·Philip Murray, Adam Stevens, Chiara De Leonibus, Ekaterina Koledova, Pierre Chatelain, Peter Clayton	15
6	Recommended methodology for determination of design groundwater levels 2015 ·UWA Profiles and Research Repository (University of Western Australia) ·(unknown), Peter Clayton, (unknown)	2
7	3-M syndrome: a growth disorder associated with IGF2 silencing 2013 ·Endocrine Connections ·Philip Murray, Dan Hanson, (unknown), Adam Stevens, Andrew Whatmore, (unknown), Deborah Mackay, Graeme C. Black, Peter Clayton	17
8	The relationship between Vitamin D and HbA1C in a type 1 diabetic paediatric population 2012 ·Lucia Magee, Zulf Mughal, Sarah Ehtisham, (unknown), Judith Campbell, SUSAN AINSWORTH, (unknown), Ian Doughty, Peter Clayton	2
9	eServices provisioning in a community development context through a JADE MAS platform 2009 ·(unknown), (unknown), Peter Clayton	5
10	Growth hormone and cancer risk 2007 ·Endocrinology and Metabolism Clinics of North America ·Peter Clayton, Indraneel Banerjee	2
11	Part II: Defining and managing growth hormone treatment failure 2007 ·Research Explorer (The University of Manchester) ·Ron G. Rosenfeld, Stephen M. Rosenthal, Pinchas Cohen, Peter Clayton, Philippe Backeljauw, Peter Bang, Svetlana Ten	1
12	A new X-linked mental retardation (XLMR) syndrome with late-onset primary testicular failure, short stature and microcephaly maps to Xq25–q26 2007 ·European Journal of Medical Genetics ·Deirdre Cilliers, (unknown), Peter Clayton, S A Cairns, (unknown), Stephen M. Shalet, Graeme C. Black, William G. Newman, Jill Clayton‐Smith	2
13	Familial Isolated Growth Hormone Deficiency Is Associated with Increased Systolic Blood Pressure, Central Obesity, and Dyslipidemia 2002 ·The Journal of Clinical Endocrinology & Metabolism ·José Augusto Soares Barreto-Filho, (unknown), Roberto Salvatori, (unknown), Antônio Carlos Sobral Sousa, (unknown), Anita H. O. Souza, Rossana M. C. Pereira, Peter Clayton, Matthew S. Gill, Manuel H. Aguiar‐Oliveira	80
14	Endocrinology and diabetes 2002 ·Archives of Disease in Childhood ·David Iles, H. Rao Gattamaneni, (unknown), Jennifer E. Thorne, Colin P. West, David A. Price, Peter Clayton, Catherine Hall	3
15	Creating a Web-based Spatiotemporal GIS using Java and VRML 1999 ·World Conference on WWW and Internet ·Peter Clayton, George Wells, (unknown)	0
16	Email Surveys: Old Problems with a New Delivery Medium 1996 ·Peter Clayton, (unknown), (unknown)	6
17	Property as an investment medium : its role in the institutional portfolio 1993 ·(unknown), Peter Clayton	4
18	Japanese Management Theory and Library Administration. 1992 ·The Journal of Academic Librarianship ·Peter Clayton	1
19	Conspectus Reconsidered 1990 ·Australian Academic & Research Libraries ·Peter Clayton	2
20	Disinfection of upper gastrointestinal fibreoptic endoscopy equipment: an evaluation of a cetrimide chlorhexidine solution and glutaraldehyde. 1978 ·Gut ·D Carr-Locke, Peter Clayton	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact